Key facts
- Averto Medical’s last known valuation is $60.5M.
- It has raised $33.5M; the latest was Later Stage VC ($30.5M) in May 2024.
- Notable investors include US National Science Foundation, MedTech Innovator, National Institutes of Health, Venrock, Cormorant Asset Management — 12 tracked in total.
- Status: Privately Held (backing).
Investors
12+- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Averto Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Averto Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Averto Medical
Manufacturer of a medical device intended to replace multiple surgical procedures and complications. The company manufactures devices that aim to facilitate minimally invasive colorectal tumor removal and gastrointestinal disease surgeries, enabling healthcare professionals to provide optimal care to patients.
- Sector
- Healthcare
- HQ
- Fremont, CA, United States
- Founded
- 2016
- Employees
- 8
- Website
- avertomed.com/
- Ownership
- Privately Held (backing)
Averto Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Averto Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Averto Medical in its N-PORT filings yet. We sweep new filings monthly.